Patent · US Active

Engineered Cas9 nucleases

US11098297B2 · kind B2 · utility

2Cited by
86References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 19, 2019
Grant dateAug 24, 2021
Priority date—
Expiry dateAug 19, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2800/80
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present disclosure relates to Cas9 nuclease variants and methods of producing and using such variants.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.